DOCS News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

DO

Mkt Cap

$5.52B

Volume

2.72M

Next Earnings

November 5th

Loading chart

DO

DOCSDoximity, Inc.

DOCS

Pay with—

Available Balance0.00

DO

Mkt Cap

$5.52B

Volume

2.72M

Next Earnings

November 5th

Chart Financials Earnings News About Insider Filings

ROSEN, LEADING INVESTOR COUNSEL, Encourages Millrose Properties, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRPRosen Law Firm has filed securities class action lawsuits against Millrose Properties, Hims & Hers Health, and Doximity for alleged disclosure failures and misleading statements to investors. Millrose Properties is accused of misrepresenting its business objectives and leasing properties at a loss. Investors have until December 8, 2026 to move the court to serve as lead plaintiff.GlobeNewswire Inc. · Oct 16, 2026

Why Doximity (DOCS) Dipped More Than Broader Market TodayDoximity (DOCS) closed at $30.71, down 2.51%, underperforming the S&P 500. The medical social networking company is scheduled to report earnings on November 5, 2026, with projected EPS of $0.34 (down 24.44% YoY) and revenue of $170.66 million (up 1.27% YoY). The stock holds a Zacks Rank #3 (Hold) with a Forward P/E of 23.61, trading at a discount to its industry average.Zacks Investment Research · Oct 16, 2026

Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor HarmA class action lawsuit has been filed against Doximity, Inc. alleging securities fraud. The complaint claims Doximity overstated its Newsfeed's revenue impact, was losing market share to competitors, and misrepresented its advertising practices. Investors who purchased Doximity securities between August 8, 2024 and May 13, 2026 may be eligible to join the case, with a lead plaintiff deadline of November 16, 2026.GlobeNewswire Inc. · Oct 15, 2026

Doximity Deepens U.S. News Alliance to Improve Patient Access to CareDoximity announced an extension of its 13-year partnership with U.S. News & World Report, continuing to provide physician data for Doctor Finder, Patient Connect appointment-booking tools, and Expert Opinion surveys for hospital rankings. The partnership leverages Doximity's network of 3+ million medical professionals to connect patients with healthcare providers. Despite the news, DOCS stock declined 2.1% following the announcement and is down 32.4% year-to-date.Zacks Investment Research · Oct 15, 2026

Tempus AI Expands Strategic Collaborations to Drive Future GrowthTempus AI (TEM) is strengthening its precision medicine presence through multiple strategic collaborations, including support for Moderna and Merck's cancer therapy commercialization and an extended data partnership with Recursion Pharmaceuticals through 2029. However, TEM's stock has underperformed the industry by 30.6% over the past year and trades at a premium valuation of 6.73X forward P/S versus the industry average of 4.90X, with the stock currently rated a Hold.Zacks Investment Research · Oct 12, 2026

רוזן, משפטן מדורג מוביל גלובלי, מעודד את משקיעי Doximity, Inc לגייס ייעוץ משפטי לפני המועד האחרון החשוב בתביעה ייצוגית בניירות ערך – DOCSRosen Law Firm reminds investors who purchased Doximity, Inc. (DOCS) shares between August 8, 2024 and May 13, 2026 of the November 16, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges Doximity misrepresented the impact of its news feed feature on revenue growth while losing market share to competitors with better pricing and user engagement models.GlobeNewswire Inc. · Oct 10, 2026

Sprout Social Investor News: If You Own Stock in Sprout Social, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your RightsRosen Law Firm has announced an investigation into potential breaches of fiduciary duties by directors and officers of Sprout Social, Inc. The firm is encouraging shareholders to contact them regarding their rights. Additional securities class action investigations are also underway for Doximity, Inc. and UWM Holdings Corporation.GlobeNewswire Inc. · Oct 10, 2026

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCSRosen Law Firm is urging investors who purchased Doximity common stock between August 8, 2024 and May 13, 2026 to join a securities class action lawsuit before the November 16, 2026 lead plaintiff deadline. The lawsuit alleges that Doximity overstated the revenue impact of its Newsfeed feature, lost market share to competitors, and relied on less effective engagement tactics, causing investor damages when the truth emerged.GlobeNewswire Inc. · Oct 10, 2026

DEADLINE ALERT for BETR, DOCS, BIDU, UWMC: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class ActionsLaw Offices of Howard G. Smith has filed securities fraud class action lawsuits against four publicly-traded companies: Better Home & Finance (BETR), Doximity (DOCS), Baidu (BIDU), and UWM Holdings (UWMC). The lawsuits allege that defendants made materially false statements and failed to disclose material adverse facts about their business operations. Investors have until specified deadlines in October and November 2026 to file lead plaintiff motions.GlobeNewswire Inc. · Oct 7, 2026

Doximity (DOCS) Surpasses Market Returns: Some Facts Worth KnowingDoximity (DOCS) closed at $28.58, up 2.33%, outperforming the S&P 500's 0.66% gain. The stock has gained 6% over the past month despite the Medical sector declining 3.74%. Upcoming earnings are expected to show an EPS of $0.34 (down 24.44% YoY) with revenue of $170.66 million (up 1.27% YoY). The company holds a Zacks Rank #3 (Hold) with a Forward P/E of 20.93, trading at a discount to its industry average of 31.16.Zacks Investment Research · Oct 5, 2026

to start trading

DO

DOCSDoximity, Inc.

DOCS

Pay with—

Available Balance0.00

Your PositionYou don't own any DOCS yet.

Related Tickers

Earnings